Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Textiles Press Releases.
Press releases published on May 27, 2025
TopFX Celebrates 15 Years of Growth in Trading and Liquidity Services
GlobeNewswire
·
May 27, 2025
Mahé, Seychelles, May 27, 2025 (GLOBE NEWSWIRE) -- TopFX is proud to mark its 15th anniversary, celebrating a significant milestone in its journey of providing world-class forex trading solutions, deep liquidity access, and innovative trading technology to …
Bion Announces First Offtake Commitments for its Organic Nitrogen Fertilizer
GlobeNewswire
·
May 27, 2025
Billings, MT, May 27, 2025 (GLOBE NEWSWIRE) -- Bion Environmental Technologies, Inc. (OTC QB: BNET), a leader in advanced livestock and organic waste treatment and resource recovery technology, announced it has received the first Letters of Interest (LOI) …
ZenaTech Provides Quantum Computing Update on ‘Clear Sky' Weather Forecasting Project─AI Drone Swarms to Combat Steep Rise in Billion Dollar Extreme Weather Events
GlobeNewswire
·
May 27, 2025
VANCOUVER, British Columbia, May 27, 2025 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) ("ZenaTech"), a technology company specializing in AI (Artificial Intelligence) drones, Drone as a Service (DaaS), Enterprise SaaS, and …
BioNTech präsentiert auf der ASCO-Jahrestagung 2025 Fortschritte aus der diversifizierten Onkologie-Pipeline
GlobeNewswire
·
May 27, 2025
MAINZ, Deutschland, 27. Mai 2025 -- BioNTech SE (Nasdaq: BNTX, „BioNTech“ oder „das Unternehmen“) wird auf der Jahrestagung der American Society of Clinical Oncology („ASCO“), die vom 30. Mai bis 3. Juni 2025 in Chicago, Illinois, stattfindet, klinische …
BioNTech to Present Progress Across Diversified Oncology Pipeline at the 2025 ASCO Annual Meeting
GlobeNewswire
·
May 27, 2025
MAINZ, Germany, May 27, 2025 -- BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will present clinical trial data from select pipeline candidates across the Company’s diversified oncology portfolio at the American Society of Clinical Oncology (“ASCO …
Ocean Power Technologies Earns “Trusted Operator” Status in New AUVSI Maritime Certification Program
GlobeNewswire
·
May 27, 2025
MONROE TOWNSHIP, N.J., May 27, 2025 (GLOBE NEWSWIRE) -- Ocean Power Technologies, Inc. (NYSE American: OPTT) (“OPT” or the “Company”), a leader in innovative, cost-effective, low-carbon and artificial intelligence maritime services that enable safer and …
KULR Technology Group Set to Join Russell 3000® Index
GlobeNewswire
·
May 27, 2025
HOUSTON, May 27, 2025 (GLOBE NEWSWIRE) -- KULR Technology Group, Inc. (NYSE American: KULR) (the "Company" or "KULR"), a global leader in sustainable energy management, today announced it is set to join the broad-market Russell 3000® Index, effective after …
Breaking News: Rasool Rezvani (RZ) Named Among the Most Influential Crypto Figures of 2025
GlobeNewswire
·
May 27, 2025
Dubai, UAE, May 27, 2025 (GLOBE NEWSWIRE) -- In a major recognition of global impact and innovation, Rasool Rezvani—widely known as RZ—has been officially named one of the Top Crypto Entrepreneurs of 2025, according to a recent report by International …
Bridger Aerospace Announces Signing of Sale Leaseback Transaction for its Headquarters Campus; Strengthening Balance Sheet and Reducing Annual Interest Expense
GlobeNewswire
·
May 27, 2025
BELGRADE, Mont., May 27, 2025 (GLOBE NEWSWIRE) -- Bridger Aerospace Group Holdings, Inc. (“Bridger,” “the Company” or “Bridger Aerospace”), (NASDAQ: BAER, BAERW), one of the nation’s largest aerial firefighting companies, today reported that it has signed …
Candel Therapeutics to Host Investor Conference Call Featuring Expert Clinical Perspectives on CAN-2409 Phase 3 Prostate Cancer Data Following 2025 ASCO Presentation
GlobeNewswire
·
May 27, 2025
NEEDHAM, Mass., May 27, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, today …
Inseego Selected for Preliminary Inclusion in the Russell 2000® Index
GlobeNewswire
·
May 27, 2025
SAN DIEGO, May 27, 2025 (GLOBE NEWSWIRE) -- Inseego Corp. (Nasdaq: INSG) (“Inseego” or the “Company”), a global leader in wireless broadband, including 5G mobile broadband and 5G fixed wireless access (FWA) solutions, today announced it has been selected …
IMUNON Invited to Present Translational Data in Supporting Remarkable Phase 2 Ovarian Cancer Survival Results at ESMO Gynaecological Cancers Congress 2025
GlobeNewswire
·
May 27, 2025
Presentation at ESMO will follow oral 2025 ASCO Annual Meeting presentation highlighting unprecedented survival data from Phase 2 OVATION 2 Study of IMNN-001 Simultaneously publication in leading peer-reviewed journal Gynecologic Oncology details IMNN-001’ …
BioXcel Therapeutics Receives Positive Recommendation from Data Safety Monitoring Board (DSMB) to Continue SERENITY At-Home Pivotal Phase 3 Safety Trial for Acute Treatment of Agitation Associated with Bipolar Disorders or Schizophrenia
GlobeNewswire
·
May 27, 2025
DSMB recommended the continuation of trial as planned Topline data expected in Q3 2025 NEW HAVEN, Conn., May 27, 2025 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence to develop …
GridCARE Launches with a Mission to Eliminate AI’s Biggest Bottleneck: Immediate Access to Power
GlobeNewswire
·
May 27, 2025
REDWOOD CITY, Calif., May 27, 2025 (GLOBE NEWSWIRE) -- GridCARE, a new company powering the AI revolution, emerged from stealth today. The company has closed a highly oversubscribed $13.5 million Seed financing round led by Xora, a deep technology venture …
XOMA Royalty Purchases Mezagitamab Royalty and Milestone Rights Held by BioInvent International for up to USD $30 Million
GlobeNewswire
·
May 27, 2025
EMERYVILLE, Calif. and LUND, Sweden, May 27, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (NASDAQ: XOMA), the biotech royalty aggregator, and BioInvent International AB (“BioInvent”) (Nasdaq Stockholm: BINV), a biotech company focused on the discovery …
ARS Pharmaceuticals to Participate in Upcoming Investor Conferences
GlobeNewswire
·
May 27, 2025
SAN DIEGO, May 27, 2025 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and their caregivers to better protect themselves from allergic reactions that could lead to …
NevGold Announces Upsize to C$6M Brokered Private Placement Financing
GlobeNewswire
·
May 27, 2025
“NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES.” VANCOUVER, British Columbia, May 27, 2025 (GLOBE NEWSWIRE) -- NevGold Corp. (“NevGold” or the “Company”) (TSXV:NAU) (OTCQX:NAUFF) (Frankfurt:5E50) is …
America’s Car-Mart Kicks Off Annual Community Fan Drive
GlobeNewswire
·
May 27, 2025
For more information, contact Media.Relations@Car-Mart.com ROGERS, Ark., May 27, 2025 (GLOBE NEWSWIRE) -- America’s Car-Mart, Inc. (Nasdaq: CRMT) announced its annual Community Fan Drive, a company tradition conducted every May and June. For over 25 years, …
Nautilus Biotechnology to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference
GlobeNewswire
·
May 27, 2025
SEATTLE, May 27, 2025 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the proteome, today announced the company will be participating in the …
NeurAxis to Participate in the Lytham Partners Spring 2025 Investor Conference on May 29, 2025
GlobeNewswire
·
May 27, 2025
CARMEL, Ind., May 27, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating conditions in children and adults …